With the emergence of the COVID-19 pandemic that spread globally at an accelerated pace, healthcare resources at all levels were shifted away from the management and prevention of chronic diseases to contain the outbreak. Prolonged lock-downs have led to reduced access to healthcare, a sudden drop in the referrals to physicians, and a reduction in the hospitalization of patients for treatment of conditions other than the COVID-19 infection. Reports suggest a partial or complete disruption of services for chronic patients across many countries worldwide. Options for community-based support and care for such patients are limited, thereby leading to a serious concern about the effect of the pandemic on the long-term clinical outcomes of patients with chronic diseases.
Wellthy Therapeutics is a digital therapeutics (DTx) company that helps healthcare stakeholders to improve patient outcomes. Its digital therapeutics platform works to manage and improve complex clinical conditions, and works closely with pharma, med device, life insurers, health insurers and healthcare systems to achieve the same.
Wellthy Therapeutics’ platform develops and deploys digital therapeutic candidates for commercialisation in indications across cardiology, nephrology and diabetes, and is live in two countries. The company has 20+ publications showcasing its real-world evidence. For more information, please visit www.wellthytherapeutics.com .
Co-Founder & CEO
Abhishek Shah is the Co-Founder of Wellthy Therapeutics, a digital therapeutics company that uses artificial intelligence (AI) and patient centric design to improve patient outcomes for all stakeholders in chronic disease management. Abhishek Shah co-founded Wellthy with the mission to transform chronic care in India by driving digital therapeutics that will improve health literacy, facilitate behavior change and help reverse and control diabetes.
Abhishek Shah comes with more than a decade of healthcare experience, having previously co-led an early stage fund as a venture capitalist, been an entrepreneur in residence, and held leadership positions in his healthcare family businesses. He holds a B.S. in Chemical and Biomolecular Engineering from Georgia Tech and an MBA from the Indian School of Business (ISB).
Link to his LinkedIn profile : https://www.linkedin.com/in/abhinshah/
Co-Founder & VP - Enterprise Partnerships
Prayat believes that improved patient outcomes lead to better business outcomes. He leads enterprise sales to insurance, pharmaceutical and med device companies. Previously, he worked with KPMG and PWC. He has an MBA from the Indian School of Business and a Bachelors in Science from Nanyang Technical University, Singapore.
Link to his LinkedIn profile : https://www.linkedin.com/in/prayat-shah-3b992429/